arrow
G

Giosuè Scognamiglio

istituto nazionale tumori irccs fondazione g pascale
H指数:35
被引数:3,665
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. J. Pers. Med. 2022, 12, 1993

撤回:Zito Marino等人。AXL和MET酪氨酸激酶受体共表达作为恶性胸膜间皮瘤的潜在治疗靶点。J. Pers. Med. 2022, 12, 1993

2026-06-300
OA
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial

肿瘤浸润性白细胞作为接受贝伐珠单抗治疗的卵巢癌患者的预后生物标志物:来自IV期MITO16A/MaNGO OV-2临床 trial 的结果

2025-11-170
OAAI
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin plus paclitaxel/avelumab (MITO-END3 trial)

外周单核细胞源性抑制性细胞与单中心接受卡铂联合紫杉醇/阿维单抗治疗子宫内膜癌患者分子亚型的相关性(MITO-END3试验)

2025-04-170
OA
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study

接受贝伐单抗联合一线化疗的卵巢癌患者的TP53突变和生存率: MITO16A/MaNGO OV-2研究的结果

2024-10-160
OAAI
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
2024-07-014
PRE
Immune cell infiltration and inflammatory landscape in primary brain tumours

原发性脑肿瘤中的免疫细胞浸润和炎症景观

2024-05-300
OAAI
A multicentric study of radiomics and artificial intelligence analysis on contrast-enhanced mammography to identify different histotypes of breast cancer

乳腺x线造影的影像组学和人工智能分析的多中心研究,以识别乳腺癌的不同组织类型

2024-05-172
PRE
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

rs822336与C/ebp β 和NFIC的结合调节PD-L1表达的诱导并预测晚期NSCLC的anti-PD-1/PD-L1治疗

2024-03-257
OAAI
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms

rs822336作为晚期NSCLC anti-PD-1/PD-L1免疫治疗的预测性生物标志物: 分子机制

2024-03-220
PRE
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

来自胃肠道的寡转移肿瘤: 临床和分子驱动因素的鉴定: 预测研究

2023-10-190
OAAI
Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial
2023-04-112
OAAI
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
2022-08-312
OAAI
Characterization of KRAS Mutational Regression in Oligometastatic Patients
2022-07-2210
OAAI
Hierarchical graph representations in digital pathology

数字病理学中的层次图表示

2022-01-0177
OA